Navigation Links
Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013
Date:11/20/2009

NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013

http://www.reportlinker.com/p0164998/Oncology-Roadmap-Brand-Spending-Benchmarks-and-Market-Forecast-to-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Comprehensive Forecasts and Detailed Budget Benchmarks new report, "Oncology Roadmap," explores the fiercely competitive oncology market in a way that no other available forecast can match.

Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever.

At the same time, brand budget benchmarks reveal spending in key areas throughout development and launch.

Uncover Oncology Threats and Opportunities

Equip your teams with the most comprehensive forecast of the oncology marketplace -- from today's stalwarts to tomorrow's blockbusters.

Product Breakdown

112 Anti-cancer drugs in all major classes

15 Adjuncts

Product Profile Components

-Product history

-Competitive and strategic positioning

-Market growth opportunities

-Sales history and projections

-Drug's materiality to company

Budget Brand Resources for Development and Launch

Track real brand spending from the pre-clinical period through the first year on the market

Brand Spending Benchmarks

-Advertising and promotion

-Medical affairs

-Decision support (market research)

-Market access

    Summary

    Brand Spending Benchmarks

    Average brand spending by budget category:

    - Advertising and promotion

    - Medical affairs

    - Decision support (market research)

    - Market access

    Average brand spending by development stage:

    - Pre-Clinical to phase 2

    - Phase 3a

    - Phase 3b

    - First year on the market

    Product Profiles by Class

    Brand Information

    - Brand and generic name

    - Drug class

    - Delivery mechanism

    - Line of treatment

    Sales Data

    - Historical/current sales

    - Forecasted sales

    Approved Indications

    - Current Product Development Phases

    - Competitive and Strategic Positioning

    - Market Opportunities and Brand Growth

    - Patent, Generic and Litigation Information

    Oncology Indication Analysis

    - Current sales, major drugs and important companies

    - Forecasted sales and assessment of future drugs and market players

    - Pipeline development status

    - Major market events, changes in treatments, patent expirations, etc.

    Companies' Oncology Portfolios

    - Current sales, major drugs and important companies

    - Forecasted sales and assessment of future drugs and market players

    - Pipeline development status

    Companies mentioned

    Amgen AstraZeneca Bristol-Myers Squibb Celgene Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Roche and Genentech Sanofi-Aventis Schering-Plough

    To order this report:

    Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013

    http://www.reportlinker.com/p0164998/Oncology-Roadmap-Brand-Spending-Benchmarks-and-Market-Forecast-to-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

    More market research reports here!

    
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626
    
    
    
    
    

    SOURCE Reportlinker


    '/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... ODU, a worldwide leader in designing ... advanced highly customizable contact technology solutions. , ODU Single Contact Technology portfolio includes: ... for a wide range of applications that require customization from industries like emobility, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... ... 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering insurance ... launching a charity drive to raise funds that will benefit the Marine Corps League. ... and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team ...
(Date:12/7/2016)... ... December 07, 2016 , ... The ... its fully redesigned website, which launched October 17, 2016, features comprehensive information regarding ... and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology treatments ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... service based in Dallas, Texas, is condemning "scam operations" carried out by unethical ... to bring these scam operations to a halt. According to Texas Premier Locksmith, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016 KEY FINDINGS ... benefits such as reducing loss of blood during ... cardiac arrests, rapid recovery after surgeries, and decreasing ... be segmented into convective warming system, surface warming ... turn reduce the stay at hospitals thus, lowering ...
(Date:12/7/2016)... DUBLIN , Dec 7, 2016 Research ... Product, Application and End User - Global Forecast to 2021" report ... , , ... reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% ... such as the growing prevalence of cancer and rapidly increasing geriatric population ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology: